Clinical Cardiology Alert – May 1, 2021
May 1, 2021
View Issues
-
New Treatment for Postural Orthostatic Tachycardia Syndrome
A study of ivabradine in patients with the common hyperadrenergic subtype of the postural orthostatic tachycardia syndrome led to slower standing heart rates, lower plasma norepinephrine levels, and improved quality of life after one month.
-
ECG Abnormalities in Elite Male and Female Athletes
A study of elite international soccer athletes of both sexes revealed women more often recorded what would be considered abnormal ECGs — only to return normal echocardiograms. This knowledge is especially valuable when treating those who have recovered from COVID-19.
-
Efficacy of the Ross Procedure in Young Adults with Aortic Valve Disease
Young patients who underwent the Ross procedure recorded high rates of survival and low rates of reintervention long term.
-
Importance of Atherosclerotic Disease Risk Factors in Myocardial Infarction Patients
ST-elevation myocardial infarction patients without standard risk factors recorded a higher all-cause mortality rate that was particularly evident in women. Using proper therapy in these patients may attenuate this risk.
-
Another Agent for Hypercholesterolemia
A pooled analysis of three randomized, controlled trials of inclisiran in patients with atherosclerotic cardiovascular disease or its risk equivalent showed impressive reductions in LDL cholesterol with subcutaneous injections every six months.